Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
Eugene HanEun Young LeeB K KimJ Y ParkDo Young KimS H AhnB-W LeeE S KangB-S ChaK-H HanSeung-Up KimPublished in: Alimentary pharmacology & therapeutics (2018)
Sarcopenia is associated with significant fibrosis in subjects with chronic hepatitis B, specifically those with obesity, insulin resistance, metabolic syndrome and liver steatosis.